Multimodality Monitoring Directed Management of Traumatic Brain Injury

  • Research type

    Research Study

  • Full title

    Multimodality Monitoring Directed Management of Traumatic Brain Injury

  • IRAS ID

    214040

  • Contact name

    Adel Helmy

  • Contact email

    adelhelmy@doctors.org.uk

  • Sponsor organisation

    Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge

  • Clinicaltrials.gov Identifier

    NCT02993549

  • Duration of Study in the UK

    4 years, 11 months, 29 days

  • Research summary

    Head injury (Traumatic Brain Injury, TBI) is a common cause of death and disability. Our current treatments focus on preventing further (secondary) injury by monitoring the pressure inside the head (intracranial pressure, ICP) and treating it. Many other monitors, including brain tissue oxygen and metabolism (how the brain generates energy), have been proven to reflect secondary injury to the brain and they are used routinely in all head injury patients in Neurointensive Care. Despite the wide use of these monitors, there is no accepted protocol to determine which treatment is most appropriate in each situation when the information from all the monitors is combined. An international consensus meeting in 2014 identified this as a key research question that would allow us to use the monitoring in a more structured way that can improve outcomes from head injury. We have designed a study protocol that combines the information from all the monitors (so called multi-modality monitoring), based on the research data from the consensus meeting, and allows us to pick treatments in a rational and consistent way. After each treatment is used (e.g. raising blood pressure, increasing oxygen through a ventilator) we can use the multi-modality monitoring to prove that we are improving the environment for the injured brain. In addition, we would like to explain why some patients respond to specific treatments. We will do this by collecting detailed data on each patient as well as any biological samples that are already available in intensive care.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    17/LO/0587

  • Date of REC Opinion

    16 May 2017

  • REC opinion

    Further Information Favourable Opinion